Mobile
Search
Advanced search
Multi-criteria search
Who are we ?
Log in
Sign up
Français
English
Kusajili – Clinical trials directory
Result
of your search per sponsor: Biogen Idec Inc
Woman and Man Max 99 years
Biogen Idec Inc
Update Il y a 4 ans
A Multicenter Study to Evaluate the Effect of Rituximab (IDEC-102) on Primary Humoral Response, Recall Response, and Maintenance of Acquired Immunity to Specific Antigens
The objective of this study is to determine whether therapy with rituximab alters the immune response in relapsed or refractory, low-grade or follicular, CD20+, B-cell NHL subjects in comparison to un...
Country
None
organs
None
Specialty
None
unknown
More information
Woman and Man Max 99 years
Biogen Idec Inc
Update Il y a 4 ans
Double-Blind, Placebo-Controlled, Dose-Ranging Study to Determine the Efficacy and Safety of BG00012 in Subjects with Relapsing-Remitting Multiple Sclerosis
The primary objective of this study is to determine the efficacy of three dose levels of BG00012 on brain lesion activity as measured by MRI in subjects with relapsing-remitting MS when compared to pl...
Country
None
organs
None
Specialty
None
Closed trial
More information
Biogen Idec Inc. (USA)
Update Il y a 4 ans
Phase IIa trial of interferon-beta-1a (Avonex) in patients with rheumatoid arthritis
Not provided at time of registration
Country
None
organs
None
Specialty
None
Closed trial
More information